exteRNA

–/10Traction

The startup develops RNA-targeted therapeutics designed to regulate gene expression for cancer treatment. By focusing on RNA biology, the company aims to provide precise interventions that can improve patient outcomes in oncology.

Melbourne, Australia · HQ

7200+ followers

Biotechnology

Updated 4 months ago

Funding

Raised to date

$11MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

IpgroupanzNo round attributed

ipgroupanz.com (opens in a new tab)investor website

Tinalley VenturesNo round attributed

tinalleyventures.com (opens in a new tab)investor website

Funding rounds are not available yet.

Founders

1 founder

Siro Perez

Co-Founder

Product

Features

The startup develops RNA-targeted therapeutics designed to regulate gene expression for cancer treatment. By focusing on RNA biology, the company aims to provide precise interventions that can improve patient outcomes in oncology.